Millions of Indians are suspected to be carriers of the drug-resistant bug After the scary New Delhi metallo-beta-lactamase-1 or the “Superbug” was detected two years ago, the world is now faced with the community-acquired methicillin-resistant staphylococcus aureus (ca-MRSA) bacterium that is resistant to almost all common antibiotics. In India, where poor hygiene and the availability of over-the-counter antibiotics lead to development of resistance, an estimated 100 to 200 million people are reportedly...

-The Associated Press   She waited 1 1/2 hours at the hospital, only to see a nurse who yelled that she was "lying about being in labor." Three hours later, her baby was born dead. Another woman gave birth on the street, steps away from a clinic that twice turned her away, saying her time had not come. Several other women interviewed by Human Rights Watch said their legs were pinched and faces slapped...

-The Hindu   The ‘New Delhi Superbug' remains “a global concern” because of its resistance to all antibiotics available in the world, according to a senior WHO official. “The ‘New Delhi metallo-beta-lactamase-1' bacteria carrying these mechanisms is a gene that includes the possibility of making anti-microbials not effective,” the official, Carmem Lucia Pessoa Da Silva, said. The NDM-1 had already been identified in several patients and countries. The WHO launched the Global Infection...

NDM-1, a result of large scale misuse of antibiotics, says dean A recent survey in the Sassoon Hospital here showed that 20 out of 3,172 patients were carrying the Superbug, NDM-1 gene. Sixty-six per cent of the patients also showed multidrug resistance. While it is not a cause for immediate worry, experts say, the high level of resistance to drugs could mean that soon there will be no antibiotics which can...

Says it receives far more submissions than the space to publish British medical journal The Lancet has refused to publish India's rebuttal in connection with an article in which a drug-resistant Superbug was named after New Delhi. The National Centre for Disease Control (NCDC), in the rebuttal, disagreed with the naming of the bacteria as New Delhi Metallo Beta-lactamase-1. However, Lancet Editor Richard Horton, while on a visit to India later, apologised...